Activational role of cannabinoids on movement

被引:166
作者
Sañudo-Peña, MC
Romero, J
Seale, GE
Fernandez-Ruiz, J
Walker, JM
机构
[1] Brown Univ, Dept Psychol, Schrier Res Lab, Providence, RI 02912 USA
[2] Univ Complutense Madrid, Fac Med, Dept Biochem, E-28040 Madrid, Spain
关键词
Delta(9)-tetrahydrocannabinol; activity; cannabinoid; biphasic effect; movement;
D O I
10.1016/S0014-2999(00)00044-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cannabinoid's major effect on movement is hypoactivity. Nevertheless, a biphasic excitatory/inhibitory effect of cannabinoids on movement has been repeatedly acknowledged. However, the literature is lacking a detailed description of such an effect. In this study, we performed a dose-response study of the effects of hg-tetrahydrocannabinol on movement. Immediately after the administration of vehicle or a dose of Delta(9)-tetrahydrocannabinol (0.2, 0.5, 1, 1.5, 2, 2.5, 3, 4, or 5 mg/kg), the animal was placed in an activity monitor and observed for 1 h. Several parameters were recorded. The horizontal and vertical activities were measured as the number of photobeams broken between the photocells on the walls of an activity monitor. The number of wet dog shakes, scratches with hindpaw, mouth movements, forepaw flutters were also recorded, as was the amount of time in minutes that each subject spent grooming. The number of fecal boluses was recorded as an index of autonomic activity. Each animal was subsequently tested for catalepsy in the bar test. A triphasic effect was observed: low doses of the cannabinoid receptor agonist Delta(9)-tetrahydrocannabinol (0.2 mg/kg) decreased locomotor activity while higher doses (1-2 mg/kg) dose-dependently stimulated movement until catalepsy emerged (2.5 mg/kg) accompanied by decreases in activity. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:269 / 274
页数:6
相关论文
共 64 条
[1]   THE FUNCTIONAL-ANATOMY OF BASAL GANGLIA DISORDERS [J].
ALBIN, RL ;
YOUNG, AB ;
PENNEY, JB .
TRENDS IN NEUROSCIENCES, 1989, 12 (10) :366-375
[2]   STRUCTURE ACTIVITY RELATIONSHIP OF 4 TETRAHYDROCANNABINOLS AND PHARMACOLOGICAL ACTIVITY OF 5 SEMI-PURIFIED EXTRACTS OF CANNABIS-SATIVA [J].
CARLINI, EA ;
SANTOS, M ;
CLAUSSEN, U ;
BIENIEK, D ;
KORTE, F .
PSYCHOPHARMACOLOGIA, 1970, 18 (01) :82-&
[3]   Time-dependent differences of repeated administration with Δ9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by μ-opioid and CB1-cannabinoid receptors in the caudate-putamen [J].
Corchero, J ;
Romero, J ;
Berrendero, F ;
Fernandez-Ruiz, J ;
Ramos, JA ;
Fuentes, JA ;
Manzanares, J .
MOLECULAR BRAIN RESEARCH, 1999, 67 (01) :148-157
[4]  
DAVIS WM, 1972, RES COMMUN CHEM PATH, V3, P29
[5]  
DEADWYLER SA, 1993, RECEPTOR CHANNEL, V1, P121
[6]   ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR [J].
DEVANE, WA ;
HANUS, L ;
BREUER, A ;
PERTWEE, RG ;
STEVENSON, LA ;
GRIFFIN, G ;
GIBSON, D ;
MANDELBAUM, A ;
ETINGER, A ;
MECHOULAM, R .
SCIENCE, 1992, 258 (5090) :1946-1949
[7]   ENZYMATIC-SYNTHESIS OF ANANDAMIDE, AN ENDOGENOUS LIGAND FOR THE CANNABINOID RECEPTOR, BY BRAIN MEMBRANES [J].
DEVANE, WA ;
AXELROD, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (14) :6698-6701
[8]  
DEWEY WL, 1986, PHARMACOL REV, V38, P151
[9]   Postnatal development of muscarinic autoreceptors modulating acetylcholine release in the septohippocampal cholinergic system - II. Cell body region: septum [J].
Disko, U ;
Haaf, A ;
Heimrich, B ;
Jackisch, R .
DEVELOPMENTAL BRAIN RESEARCH, 1998, 108 (1-2) :31-37
[10]   MAST-CELLS EXPRESS A PERIPHERAL CANNABINOID RECEPTOR WITH DIFFERENTIAL SENSITIVITY TO ANANDAMIDE AND PALMITOYLETHANOLAMIDE [J].
FACCI, L ;
DALTOSO, R ;
ROMANELLO, S ;
BURIANI, A ;
SKAPER, SD ;
LEON, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (08) :3376-3380